Driving CAR T-Cells in the Fast Lane to Market

How Leading Cell Therapy Manufacturers Use Simple Western for Faster & Superior Protein Analysis

There is high demand across the cell therapy industry for automated methods capable of generating analytical-grade results that meet regulatory standards, are easy to transfer, and are amenable to scale with manufacturing. Current methods like flow cytometry and ELISA fall short of meeting this demand, so cell therapy manufacturers are turning to alternative protein analysis solutions for their workflows, like the capillary electrophoresis-based immunoassay platform, Simple Western™.

Supported by the growing number of patent citations and research articles by leading cell therapy R&D groups, Simple Western better meets industry needs for a robust protein characterization assay with several advantages critical to cell therapy manufacturing including speed and scalable automation. By highlighting real-world examples across the development pipeline, this review seeks to connect researchers with solutions in protein analysis using Simple Western platforms that can be leveraged in cell therapy manufacturing workflows, arming them with faster alternatives and accelerating time to market.